期刊文献+

阿那曲唑阴道环中有关物质检测的方法学研究

The methodology study of related substances detection in compound anastrozole intravaginal ring
下载PDF
导出
摘要 目的:建立阿那曲唑阴道环中有关物质的高效液相色谱(HPLC)检测方法并进行方法学研究。方法:在强酸、强碱、高温、氧化剂、强光照等条件下,对注塑成型法制备的阿那曲唑阴道环进行破坏试验。利用HPLC法考察阴道环的稳定性、精密度、检测限等。HPLC检测条件为色谱柱Diamonsil C18(2)(250 mm×4.6 mm,5μm);流动相乙腈-水(42:58,v/v);检测波长210nm;流速1.0ml/min;进样量20μl;柱温35℃。结果:阿那曲唑阴道环主成分与相关杂质及降解产物均分离良好,空白辅料对测定无干扰;检测限为3ng/ml;重复性相对标准偏差(RSD)1.6%,溶液稳定性RSD为1.8%。结论:本文所建立的阿那曲唑阴道环中有关物质的测定方法操作简单、专属性强、重复性好,可以为阿那曲唑阴道环质量控制提供依据。 Objective:To establish High Performance Liquid Chromatography(HPLC)method for detecting related substances in compound anastrozole vaginal ring,and to study on methodology of the HPLC method.Methods:The compound anastrozole vaginal ring was synthesized by the way of injection molding,and the breaking test was conducted under strong acid,strong alkaline,high temperature,oxidant or strong illumination.The repeatability,stability,accuracy,and the limit of detection(LOD)of the ring were also detected by HPLC method with a column of Diamonsil C18(2)(250 mm × 4.6 mm,5μm)and UV detection at 210 nm.The mobile phase consisted of acetonitrile water(42:58,v/v)at a flow rate of 1.0 ml/min.The sample size was 20μl and column temperature was 35 ℃.Results:The result of specificity test showed that the main drug and the related impurities,degradation products were well separated.Blank excipient had no interference for determination.Anastrozole detection limit was 3 ng/ml.The RSD of the reproducibility was 1.6 % and the RSD of the stability was 1.8 %.Conclusion:The established method for detecting related substances in compound anastrozole vaginal ring has the characteristics of operative simplicity,strong specificity and good repeatability.
作者 邱顺晨 杨森 刘振齐 谷翊群 宁美英 QIU Shunchen;YANG Sen;LIU Zhenqi;GU Yiqun;NING Meiying(National Research Inslitute for Family Planning,Beijing,100081;Beijing Mum icipal Corps,Chinese Armed Police Forced,Beijin)
出处 《中国计划生育学杂志》 2018年第7期570-573,共4页 Chinese Journal of Family Planning
基金 "十三五"国家重点研发计划课题(2016YFC1000904) 中国博士后科学基金(2017M610842)
关键词 阿那曲唑 阴道环 有关物质 方法学验证 Anastrozole Intravaginal ring Related substances Methodology study
  • 相关文献

参考文献6

二级参考文献65

  • 1陈德滇,黄胜,周绍强,陈文林,杨庄青,张季,聂建云.戈舍瑞林联合阿那曲唑作为一线内分泌方案治疗绝经前伴中、高危复发转移因素乳腺癌的临床研究[J].中国癌症杂志,2011,21(3):225-227. 被引量:8
  • 2沈镇宙,宋三泰,张斌,邵志敏,陆劲松.中国绝经前女性乳腺癌患者辅助治疗后绝经判断标准及芳香化酶临床应用共识(草案修正案)[J].中国癌症杂志,2011,21(5):418-420. 被引量:19
  • 3Geisler J, King N, Anker G, et al. In vivo inhibition of aromatizatio n by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal bre ast cancer patients[J]. Clin Cancer Res, 1998, 4(8):2089.
  • 4Osborn e CK. Aromatase inhibitors in relation to other forms of endocrine therapy for breast cancer[J]. Endocr Relat Cancer, 1999, 6(2):271.
  • 5Buzdar A, Jonat W, Howell A, et al. Anastro zole, a potent and selective aromatase inhibitor, versus megestrol acetate i n postmenopausal women with advanced breast cancer: results of overview and anal ysis of two phase Ⅲ clinical trials[J]. J Clin Oncol, 1996, 14(7): 2000.
  • 6Buzdar A, Jonat W, Howell A, et al. Anastrozole versus megestr ol acetate in the treatment of postmenopausal women with advanced breast carcino ma[J]. Cancer, 1998, 83(6):1142.
  • 7Gershanovich M, Chaudri HA, Campos D, et al. Letrozole, a new oral ar omatase inhibitor: randomized trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer[J]. Ann Oncol, 1998, 9(5):639.
  • 8Dombernowsky P, Smith I, Falkson G, et al. Letrozole, a new oral arom atase inhibitor for advanced breast cancer: double-blind randomized trial showi ng a dose effect and improved efficacy and tolerability compared with megestrol acetate[J]. J Clin Oncol, 1998, 16(2):453.
  • 9Bengtsson NO, Focan C, Gudgeon A, et al. A phase Ⅲ trial comparing voro zole (RIVIZOR) versus aminoglutethimide in the treatment of advanced postmen opausal breast cancer[J]. Eur J Cancer, 1997, 33(1):148
  • 10Goss PE, Winer EP, Tannock IF, et al. Randomized phase Ⅲ trial comparin g the new potent and selective third-generation aromatase inhibitor vorozole wi th megestrol acetate in postmenopausal advanced breast cancer patients[J]. J C lin Oncol, 1999, 17(1):52.

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部